title: [Clinical approach to the identification of patients suffering from severe sepsis with several organ failures for the administration of drotrecogin alfa (activated): from the PROWESS study to clinical practice].
authors.affiliation: Département de réanimation, hôpital Cochin, Paris, France.
authors.forename: J F
authors.initials: JF
authors.lastname: Dhainaut
authors.forename: D M
authors.initials: DM
authors.lastname: Payen
authors.forename: G
authors.initials: G
authors.lastname: Bernardin
authors.forename: J L
authors.initials: JL
authors.lastname: Gérard
authors.forename: C
authors.initials: C
authors.lastname: Martin
authors.forename: D
authors.initials: D
authors.lastname: Perrotin
authors.forename: B
authors.initials: B
authors.lastname: Regnier
mesh_terms: D000465:Algorithms; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D006801:Humans; D009102:Multiple Organ Failure / Q000188:drug therapy* / Q000209:etiology*; D018579:Patient Selection; D011486:Protein C / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000627:therapeutic use*; D018570:Risk Assessment; D018805:Sepsis / Q000150:complications* / Q000188:drug therapy*; D012720:Severity of Illness Index
chemical_list: D000890:Anti-Infective Agents; D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated